Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.375 USD | -1.92% | +7.44% | -31.45% |
May. 14 | Transcript : Syros Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Syros Pharmaceuticals, Inc. Agrees to Amend Its Loan Agreement with Oxford Finance LLC | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.45% | 146M | |
+35.09% | 50.85B | |
+0.59% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.71% | 26.11B | |
-21.68% | 19.13B | |
+8.63% | 13.05B | |
+26.96% | 12.16B | |
+24.41% | 12.08B |
- Stock Market
- Equities
- SYRS Stock
- News Syros Pharmaceuticals, Inc.
- Syros Pharmaceuticals : Names Jason Haas CFO